Sanofi
- SEC CIK
- 0001121404
- Latest filing
- Jul 28, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 6, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 9
- 0 vs. Q4 2024
- Portfolio value
- $165.9M
- −$8.42M (−4.8%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| MGTXMeiraGTx Holdings plc | COM | 12,197,737 | $82.7M | 49.8% | 00.0% | Unchanged | History |
| NVAXNovavax Inc | COM NEW | 6,880,481 | $44.1M | 26.6% | 00.0% | Unchanged | History |
| INBXInhibrx Biosciences, Inc. | COM | 1,157,926 | $16.2M | 9.8% | 00.0% | Unchanged | History |
| ANABAnaptysbio, Inc | COM | 821,917 | $15.3M | 9.2% | 00.0% | Unchanged | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 814,980 | $2.76M | 1.7% | 00.0% | Unchanged | History |
| LVTXLAVA Therapeutics NV | SHS | 1,919,455 | $2.44M | 1.5% | 00.0% | Unchanged | History |
| IGMSIGM Biosciences, Inc. | COM | 1,438,975 | $1.65M | 1.0% | 00.0% | Unchanged | History |
| INZYInozyme Pharma, Inc. | COM | 443,255 | $403.4K | 0.2% | 00.0% | Unchanged | History |
| QTTBQ32 Bio Inc. | COM | 244,083 | $402.7K | 0.2% | 00.0% | Unchanged | History |